PharmaKure
MRI of the patient's head close-up. One picture from the series.

PharmaKure Announces epigenetics Collaboration with Sheffield Hallam University to Understand Mechanisms of Alzheimer’s Diseases

The collaborative study between Sheffield Hallam University and aims to gain a better understanding of Alzheimer's Disease (AD) in order to identify those more at risk of developing the disease, so enabling the provision of appropriate interventions much earlier in the disease pathology.

Continue ReadingPharmaKure Announces epigenetics Collaboration with Sheffield Hallam University to Understand Mechanisms of Alzheimer’s Diseases